ScholarLens Back to search
2016•Journal of Surgical OncologyRequires access

Multimodality treatment of intrahepatic cholangiocarcinoma: A review

Kerri Ann Simo, Laura E. Halpin, Nicole M. McBrier, Jacob A. Hessey, Erin H. Baker, Samuel Wade Ross, Ryan Z. Swan, David A. Iannitti, John B. Martinie

Open publisher page 53 citations

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes.

About this research paper

What this paper is about

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes.

Why it matters

OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary hepatic cancer in the United States. Currently, curative treatment involves aggressive surgery. Chemotherapy and radiation treatments have been used for unresectable tumors with some success. Optimizing the use of current and developing novel multimodality treatment for iCCA is essential to improving outcomes.

Key concepts: Medicine, Multimodality, Intrahepatic Cholangiocarcinoma, General surgery, Radiology, Internal medicine, World Wide Web, Computer science

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Multimodality treatment of intrahepatic cholangiocarcinoma: A review — Research Paper | ScholarLens